Minority Shareholders Demand R$ 1.9 Billion Buyout in Toky Governance Battle

A major corporate governance dispute at Brazilian retail group Toky, the owner of home decor brands Mobly and Tok&Stok, is testing the enforcement of shareholder protections and poison pill bylaws in Brazil. A group of 39 minority shareholders, alongside the Institute for Integral Development (IDI), has petitioned Brazil's securities regulator, the Securities and Exchange Commission of Brazil (CVM), to force prominent asset managers SPX Capital and DSK Capital to launch a mandatory tender offer (OPA) for the company's remaining shares.

The dispute, detailed in a complaint reported by NeoFeed, centers on allegations that the two asset managers acted in concert to bypass Toky's corporate bylaws. The minority shareholders claim that SPX and DSK coordinated a series of debt-to-equity conversions and subsequent share transfers to amass a combined 30.8% stake through intermediary entities. This combined holding surpasses the 20% "poison pill" threshold established in Toky's bylaws, which is designed to protect minority investors from hostile or creeping takeovers by triggering a mandatory buyout offer.

The financial stakes of the petition are immense. The minority shareholders are demanding an OPA buyout price of R$ 1,008 per share, which would value the mandatory transaction at approximately R$ 1.9 billion. This requested price—derived from historical debt conversion formulas adjusted for recent reverse stock splits—stands in stark contrast to Toky's actual market reality. The retail group, which entered judicial reorganization in mid-2026 with over R$ 1 billion in debt, currently has a total market capitalization of only about R$ 28 million.

The accused asset managers deny any coordinated action. SPX Capital has stated that its transactions were independent and conducted at market rates, while Toky has previously argued that there is no objective evidence of a coordinated block. The minority shareholders are pressing the CVM to act swiftly ahead of a crucial shareholder meeting scheduled for November 6, 2026, which will elect a new board of directors for a two-year term. The petitioners argue that the contested shares could otherwise be used to unilaterally dictate the composition of the board.

What it touches

This corporate battle directly exposes investors in Toky's local shares (B3: TOKY3). The outcome of the CVM’s investigation will serve as a key benchmark for how strictly Brazil's regulatory framework enforces minority shareholder protections and "poison pill" provisions, especially when distressed companies undergo complex debt restructurings that dilute public equity.